Should I take 2g of EPA/DHA daily?

Omega-3 cardiovascular RCTs disagree; cognitive cohort signals are more consistent.

Our read is Partially Supported. The core mechanism holds and the direction is right, but the popular framing tends to overrun what the trials actually show. With a developing evidence base (60/100) and a working majority (62% consensus), taking 2g of EPA/DHA daily is reasonable for the right person at $25/month — just calibrate the expectation to the data, not the marketing.

Pulled the public claims about taking 2g of EPA/DHA daily from proponents on file (a tracked voice and a tracked voice) and weighed them against the more cautious voices in the field, then cross-checked each against the primary trial and cohort literature and the prevailing clinical guidance. We grade the claim against what the human evidence actually supports, not against how confidently it is stated.

• 01Expert consensus: 62% — a working majority among the voices we track.
• 02Evidence strength: 60/100, which we read as a developing evidence base.
• 03Direction of effect: real, but smaller than the popular framing of taking 2g of EPA/DHA daily implies.
• 04Best-supported slice: a specific population or protocol carries most of the signal; generalizing past it is where claims fray.
• 05Weakest link: long-term and hard-outcome data lag the mechanistic and short-term findings.

Downside risk on taking 2g of EPA/DHA daily is low at sensible doses, but low risk is not no risk: individual response varies, and a low-risk intervention is still only worth it if the benefit is real.

A large, long-duration RCT in a general population that either confirms a hard-outcome benefit or shows the effect washes out once it is properly controlled.